NEVRO CORP's ticker is and the CUSIP is 64157FAA1. A total of 22 filers reported holding NEVRO CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 27,600,000 | $33,560,000 | 1.29% |
| OAKTREE CAPITAL MANAGEMENT LP | 27,840,000 | $33,841,000 | 0.49% |
| Nicholas Investment Partners, LP | 5,530,000 | $6,692,000 | 0.47% |
| WOLVERINE ASSET MANAGEMENT LLC | 22,625,000 | $27,455,000 | 0.43% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 15,650,000 | $19,064,000 | 0.36% |
| CAMDEN ASSET MANAGEMENT L P /CA | 9,275,000 | $11,223,000 | 0.29% |
| LINDEN ADVISORS LP | 1,751,000 | $2,130,000 | 0.08% |
| LORD, ABBETT & CO. LLC | 14,387,000 | $17,480,000 | 0.05% |
| AVIVA PLC | 4,500,000 | $5,468,000 | 0.03% |
| Allianz Asset Management GmbH | 24,995,000 | $30,481,000 | 0.03% |